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Background: Little is known about the ﬁtness of the available tools in predicting functional decline of
polypathological patients (PPs). Our objective was to assess accuracy of the Triage Risk Screening Tool
(TRST), the Variable Indicative of Placement risk (VIP) and to develop a speciﬁc functional prognostic
index adjusted to this population in a multicenter cohort of hospital-based PP.
Methods: Prospective 12-month follow-up study of PPs from 36 hospitals. Functional decline was deﬁned
as loss of 20 points on Barthel’s index (BI). Accuracy of TRST/VIP was assessed by calibration/
discrimination tests. Development of the new score was performed by dividing into a derivation cohort
(constructing the index by logistic regression), and a validation cohort (in which calibration/discrimi-
nation of the index were tested).
Results: Nine hundred and ﬁfty-eight patients from the 1632 included survived during follow-up. Basal/
12-month BI was 85/70, respectively. Mean fall in BI score was 11.7 24 points [353 (36.8%) fell by 20
points]. The activities for daily living that declined most frequently were toilet use, grooming, dressing
and bathing. TRST/VIP ﬁtted well but their discrimination power was poor (area under the curve¼ 0.49
and 0.46, respectively). A simpliﬁed PROFUNCTION index was derived containing seven items (85 years,
neurological condition, osteoarticular disease, IIIeIV functional class of dyspnea, 4 polypathology
categories, basal BI< 60, and social problems). Functional decline risk ranged from 21% to 24% in the
lowest risk group (0 items) to 38e46% in the highest (4e7 items). Calibration as well as discrimination
power (area under the curve¼ 0.56e0.59) of this simpliﬁed index were good.
Conclusion: We developed and validated a new functional prognostic index speciﬁcally focused on these
patients with better discrimination power than other tools available.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Disability and dependence are, after death, two of the most
worrisome health outcomes of all diseases. Disability is of even
more concern in patients with complex chronic diseases, as well as
in polypathological patients (PPs), because of the spiral deleterious
effects of symptom loads and clinical vulnerability, which lead to
progressive functional decline, and established dependence.l, Internal Medicine Depart-
ida Manuel Siurot, s/n. 41013
eu-Wittel).
work.
iwan Society of Geriatric EmergenDependence also plays an independent role in poor outcomes and
in informal caregiver overload once established1e4.
PPs have become an emerging population in most clinical are-
nas5e7. Their prevalence in primary care, as well as in different
medical and surgical hospital areas, is remarkably high and will
probably increase in the forthcoming years6e8. Their complexity,
burden of diseases and symptoms, clinical vulnerability, poor
health-related quality of life, and an obvious trend towards func-
tional deterioration, have been previously pointed out1e3,9.
Nevertheless, functional transitions in prospective follow-up of
PPs and their predictive factors have not yet been extensively
addressed.
Functional outcome prognostication is a very useful tool for
clinicians to plan speciﬁc strategies towards functionality preserva-
tion and preventive measures against the dependence cascade2,10,11.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Functional Prognostication in Polypathology 69This is especially important in a high-risk population like PPs,
considering the deeper impact of functional decline on survival and
other important outcomes in this population1e4,6. Some of the
strongest predictors of functional decline are age, admission diag-
nosis, basal lower functional status, impaired cognitive status,
comorbidity, polypharmacy, and length of hospital stay12e14. Various
screening tools, encompassing (some of) these predictors are already
available, andhavebeen testedondifferentpopulationswith varying
overall accuracy, ranging from 49% to 76%. The most widely used
instruments are the Triage Risk Screening Tool (TRST)15,16, and the
Variable Indicative of Placement risk (VIP)17; nevertheless, their
accuracy has not yet been evaluated in PPs.
For all of the above-mentioned reasons, we developed this
multicenter project in a cohort of PPs to assess functional decline
and its main determinants over a 12-month follow-up period,
evaluate the accuracy of the aforementioned predictive tools, and
develop a new functional predictive tool speciﬁcally designed with
PPs in mind.
2. Methods
This was an observational, prospective, multi-institutional study
carried out by researchers from the Polypathological Patient and
Advanced Age Study Group of the Spanish Internal Medicine
Society. The study inclusion period ranged from February 2007 to
June 2008 (17 months). The present study has been approved by
the ethics committee of Hospitales Universitarios Virgen del Rocío.
2.1. Reference population
All PPs treated in the Internal Medicine and Geriatric areas (in-
hospital, as well as in outpatient clinics, and hospital at-home
patients) from the 36 Spanish hospitals participated in the study
(all participant centers are listed on the PROFUND Researchers list).
2.2. Inclusion criteria
Patients aged 18 years old, who met the criteria for PPs were
consecutively included, after providing their written informed
consent5. In-hospital patients were included at discharge, and
those identiﬁed at outpatient clinics (internal medicine outpatient
clinics, day hospital, and/or hospital at-home patients) were
included during any one of their visits. Patients who died during
their hospital stay or during 12 months follow-up and those who
did not agree to enter the study were excluded.
2.3. Development of the study, data collection and follow-up
After receiving informed consent, a complete set of demo-
graphic, clinical, functional, analytical, pharmacological, as well as
socio-familial data were collected from all included patients.
Demographic data included age, sex, residence, employment,
and the main caregiver’s proﬁle; clinical data included the different
diseases, the fulﬁllment of polypathology criteria, stage of different
diseases (New York Heart Association and Medical Research
Council dyspnea rates18,19, and ChildePugh stage20), assessment of
Charlson’s comorbidity index21,22, different symptoms and signs,
body mass index (BMI), assessment of basal as well as inclusion
ability in performing activities of daily living (ADL) and instru-
mental activities (IAs) by means of Barthel’s index (BI) and Law-
toneBrody (LeB) index23,24, assessment of basal cognitive
impairment using the Spanish validated version of Pfeiffer’s ques-
tionnaire (PQ)25, and number of hospital admissions in the past 12
and 3 months, respectively; analytical data included plasma
creatinine, hemoglobin, albumin, glycated hemoglobin, andultrasensitive C-reactive protein; pharmacological data included
number and type of chronically prescribed drugs at baseline; and
socio-familial data included socio-familial risk determined using
the Gijón scale (GS)26. The GS is a validated scale that assesses the
overall socio-familial situation by exploring ﬁve speciﬁc dimen-
sions (family, economics, housing, social relations and social
network support) in a 1e5 Likert scale (score rank: 5e25 points);
a score <10 confers low social risk; 10e16 confers risk of social
claudication; and> 16 points deﬁnes an established social problem.
All included patients were followed-up during a 12-month
period. After this time, survival was assessed and, in the case of
death, the patient was excluded from analysis. Primary endpoint
was functional status in the performance of ADL bymeans of the BI.
Most dimensions of the BI count 5e10 points (5e10% from total
index), therefore, we considered functional decline when the
patient lost 10 points (1e2 activities), 20 points (2e3 activities),
and 30 points (3e4 activities). We also considered the variable of
becoming dependent, deﬁned as patients with basal BI> 60 points,
whose follow-up BI fell to <60 points.
2.4. Other deﬁnitions
Nutritional status was categorized by means of World Health
Organization criteria for BMI values [overweighteobesity (BMI
> 24.9), normal weight (BMI 18.5e24.9), underweight (BMI
<18.5)]27. Hypoalbuminemia was deﬁned as albumin levels
<3.5 g/dL (severe: <1.8 g/dL, moderate: 1.8e2.69 g/dL, and slight:
2.7e3.5 g/dL). Polypharmacywas deﬁned as the chronic prescription
of at leastﬁve drugs. Dependence in functional status for ADL and IAs
was deﬁned by BI<60 points andby LeB index<8 forwomen/<5 for
men. Cognitive impairment was deﬁned by3 errors on the PQ ( 4
if the patient had not completed elementary school and 2 if the
patient had a college education); this was categorized as mildemo-
derate impairment (3e7 errors), and severe impairment ( 8 errors).
Socio-familial risk/problems were deﬁned as a GS score 10. The
need for a caregiver was deﬁned when the patient was functionally
dependent (BI <60) and/or cognitively impaired (PQ 3 errors).
We used a modiﬁed Flemish version of the TRST instrument
comprising ﬁve yes/no topics: cognitive impairment; difﬁculty in
walking, transferring; living alone with no available caregiver;
polypharmacy; and recent hospitalization. The presence of cogni-
tive impairment or two or more risk factors designates the older
person as “high risk”15,16,28. The VIP assesses older patients’ degree
of independence, with the aim of detecting patients with potential
discharge problems17. With three yes/no questions, the patients’
living situation, functional status and cognitive status were evalu-
ated. A patient was considered at risk when at least two positive
answers were reported.
2.5. Statistics
The dichotomous variables were described as whole numbers
and percentages, and the continuous variables as mean and stan-
dard deviation (or median and rank in those with no criteria of
normal distribution). The distribution of all variables was analyzed
with the KolmorogoveSmirnov test. All statistics were performed
using the SPSS version 16.0.
Bivariate relationships between potential risk factors and func-
tional decline in BI (10, 20, and 30 points, as well as becoming
dependent) were established by c2 test and Fisher test if necessary.
Signiﬁcant variables (p< 0.05) were entered into a multiple back-
wards logistic regression model to reﬁne independent risk factors
for all endpoints.
To assess accuracy of the TRST and VIP indexes in the recruited
PPs, we determined their calibration by comparing the predicted
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Fig. 1. Most affected dimensions in 12-month functional decline with respect to activities of daily living in a multicenter cohort of polypathological patients from Spain, by means of
percentages of patients with any basal/end-point dependence level in the ten Barthel’s index dimensions.
Table 1
Main features of the TRST and VIP indexes in a multicenter sample of hospital-
based polypathological patients from Spain.
Index feature Median (IQR)/N (%)
TRST
Median/mean score 2 (2e3)/2.3 0.9
Patients at low/high risk 34.6%/65.4%
Calibration (HeL test)
Loss of 10 points in BI p¼ 0.48
Loss of 20 points in BI P¼ 0.65
Loss of 30 points in BI P¼ 0.35
Discrimination (AUC)
Loss of 10 points in BI 0.48 (0.43e0.52)
Loss of 20 points in BI 0.46 (0.41e0.5)
Loss of 30 points in BI 0.41 (0.37e0.46)
VIP
Median/mean score 1 (1e2)/1.22 0.6
Patients at low/high risk 71%/29%
Calibration (HeL test)
Loss of 10 points in BI p¼ 0.28
Loss of 20 points in BI p¼ 0.22
Loss of 30 points in BI p¼ 0.23
Discrimination (AUC)
Loss of 10 points in BI 0.504 (0.47e0.54)
Loss of 20 points in BI 0.49 (0.45e0.53)
Loss of 30 points in BI 0.476 (0.43e0.52)
AUC¼ area under the curve; BI¼ Barthel’s index; HeL¼HosmereLemeshow;
IQR¼ interquartile range; TRST¼ Triage Risk Screening Tool; VIP¼Variable
Indicative of Placement risk.
M. Bernabeu-Wittel et al.70functional decline (divided into probability risk-quartiles) to the
observed functional decline by calculating the HosmereLemeshow
goodness-of-ﬁt test. Then, we evaluated their discriminatory power
by applying the point scoring system, thereby determining risk
scores for each participant, and calculating the area under the
receiver operating characteristic (ROC) curve.
Our new PP functional scale was derived and validated as
follows. We chose as the functional decline endpoint a loss of 20
points in BI (2e3 ADL) with respect to basal values. The included
population was divided into a derivation cohort (containing
approximately half of the participating hospitals, from western
regions of Spain, and patients), and a validation cohort (containing
approximately the remaining half of the participating hospitals,
from eastern regions of Spain and islands). Bivariate relationships
between potential risk factors and mortality were assessed in the
derivation cohort using logistic regression models. Signiﬁcant vari-
ables (p< 0.05) were entered into a multiple backwards logistic
regression model. Risk factors that remained signiﬁcant after
adjustment (p< 0.05) were used to create the predictive model. The
1-year functional decline risk scoring system was created by
assigning points to each risk factor [dividing each b coefﬁcient in the
model by the lowest b coefﬁcient (presence of heart valve pros-
thesis; b¼ 0.42) and rounding to the nearest integer]. To test the
stability of our ﬁnalmodel, we tried alternatemethods (forward and
bidirectional selection techniques) to determine whether the
resultingmodel would differ from our originalmodel. After this, and
knowing the narrow differences in prognosisweight of the predictor
variables (lowestehighest weights were 4e5), we attempted to
simplify the index by matching all predictive items to the unit.
To validate both the original PROFUNCTION index and the
SIMPLIFIED PROFUNCTION, we determined the calibration of the
indexes by comparing the predicted functional decline (divided
into probability risk-quartiles) from the derivation/validation
cohort to the observed functional decline, by means of the Hos-
mereLemeshow goodness-of-ﬁt test. Then, we evaluated the
discrimination of the indexes by applying the point scoring system
created in the derivation cohort to the validation cohort, thereby
determining risk scores for each participant, and calculating thearea under the ROC curve, for the ﬁnal model in both the derivation
and validation cohorts. We chose to validate our predictive indexes
in a different region of the country fromwhere it was developed to
test geographic transportability as well as diagnostic accuracy.
3. Results
A total of 1632 PPs (75% hospitalized, 17.5% outpatients, and
7.5% at-home patients) were included in the study, and 93.44%
Functional Prognostication in Polypathology 71(n¼ 1525) completed the 12-month follow-up. We ﬁnally included
in the analysis the 958 patients who survived during follow-up
(global mortality rate was 37.2%). The main demographic, clinical,
and care features of the whole inclusion cohort have already been
described elsewhere29.
Basal as well as 12-month BI of included PPs were 85 (inter-
quartile range¼ 35) and 70 (interquartile range¼ 40), respectively.
Mean fall in BI score was 11.724 points [477 (49.8%), 353 (36.8%)
and 266 (27.8%) patients developed falls of 10, 20 and 30
points, respectively]. A total of 166 patients (25% of the 739 with
basal BI 60) became dependent during follow-up. Most affected
dimensions in ADL functional decline (patients with any depen-
dence level at baseline/follow-up) are detailed in Fig. 1.
Median TRST and VIP scores were 2 (range: 2e3) and 1 (range:
1-2), respectively. In qualitative scoring, 627 patients (65.4%) were
at functional risk according to the TSRT index, and 278 (29%)
according to VIP. The detailed description of these scores is shown
in Table 1. Calibration and discrimination power of both indexes
with respect to the three endpoints (functional decline in BI 10,
20 and 30 points) are also detailed in Table 1.
3.1. Development of the PROFUNCTION INDEX and SIMPLIFIED
PROFUNCTION
Division of the cohort was performed with the patients who
completed follow-up. The comparedmain basal features of patientsTable 2
Comparative main basal clinical features of the derivation and validation cohorts of poly
Clinical features [mean SD/median (IQR)/N (%)]
Age
Sex (males)
Requiring caregiver
Number of deﬁning categories/patient
Patients with 3 categories
Prevalence of deﬁning categories in recruited PPs
Category A (heart diseases)
Category C (lung diseases)
Category E (neurological diseases)
Category B (kidney/autoimmune diseases)
Category F (peripheral arterial disease/diabetes with neuropathy)
Category G (chronic neoplasia/anemia)
Category H (degenerative osteoarticular disease)
Category D (liver disease)
Number of other comorbidities/patient
Patients with 4 other comorbidities
Most frequent other comorbidities
Hypertension
Arrhythmias
Atrial ﬁbrillation
Other arrhythmias
Diabetes without visceral involvement
Dyslipidemia
Anxiety and depressive disorders
Charlson index/Charlson index adjusted by age
Mean hemoglobin level (g/dL)
Albumin (g/dL)/body mass index
Albumin <3 g/dL
Body mass index <25
Patients with basal IIIeIV class of NYHA and/or MRC
Patients with one or more falls in last 12 mo
Hospitalizations in last 12/3 months
Patients with delirium in last hospital admission
Basal Barthel’s Index / Basal LawtoneBrody index
End-point (12 mo follow-up) Barthel’s index
Inclusion Pfeiffer scale/Gijón’s socio-familial risk scale
Number of prescribed drugs at inclusion/patients with polypharmacy
F¼ female; IQR¼ interquartile range; M¼male; MRC¼Medical Research Council; NY
deviation.in the derivation (n¼ 493) and validation (n¼ 465) cohorts are
detailed in Table 2.
Global functional decline rate in the derivation cohort was
30.4%. Seven factors (one demographic, four clinical, one functional,
and one socio-familial) were independently associated with the
primary endpoint, and for this reason were used to develop the
index (Table 3). Other possible risk factors (sex, profession, care-
giver’s age and sex, inclusion criteria, all other inclusion categories,
other comorbidities, number of other comorbidities per patient,
need for chronic home oxygen therapy, individual as well as global
IAs by means of LeB index, number of prescribed drugs, poly-
pharmacy, all analytical parameters, and hospital admissions) were
not associated with functional decline.
With respect to basal ADL, we developed different models
including the global basal BI, its 10 dimensions, and both. The two
latest models obtained poorer results in the validation cohort when
compared with the model, which included the basal global BI. For
this reason, and because the BI is a universally extended and easy-
to-perform tool in clinical practice, we ﬁnally chose the model with
this factor. The alternative strategies (forward and bidirectional
selection techniques) resulted in no differences in the resulting
prognostic variables of the modeling.
After dividing in functional decline probability quartiles in the
PROFUNCTION index and SIMPLIFIED PROFUNCTION, functional
decline ranged from 21% in the lowest, to 36% in the highest risk
quartile. The obtained calibration in the derivation cohort was goodpathological patients from Spain.
Derivation cohort (n¼ 493) Validation cohort (n¼ 465)
78 9 77.6 10
273 (56%) 241 (52%)
200 (41.6%) 198 (43.4%)
2.62 0.7 2.59 0.77
234 (47.5%) 207 (44.5%)
395 (80.1%) 368 (79.1%)
229 (46.5%) 225 (44.1%)
162 (33%) 172 (37%)
156 (31.6%) 136 (29.2%)
138 (28%), 114 (24.5%)
104 (21.1%) 99 (21.3%)
73 (14.8%) 75 (16.1%)
34 (6.9) 36 (7.7)
2.9 1.6 3.1 1.7 (p¼ 0.03)
246 (33.5 %) 287 (41%) (p¼ 0.017)
381 (77.3%) 345 (74.2%)
165 (33.5%) 174 (37.7%)
159 (32.3%) 167 (36%)
6 (1.2%) 7 (1.7%)
133 (27%) 150 (32.3%)(p¼ .07)
168 (34.1%) 149 (32%)
66 (13.4%) 66 (14.2%)
3.8 (2)/7.6 (2) 3.6 (1.8)/7.4 (1.9)
12.05 2.2 11.8 2.1
3.43 (0.6)/29 6.4 3.31 (0.7)/28.9 6.7
83 (17%) 97 (20.7%)
121 (24.5%) 121 (26.5%)
171 (34.7%) 164 (35.3%)
61 (12.5%) 105 (22%) (p< 0.001)
1.64 1.5/0.87 0.8 1.75 1.4/0.82 0.8
27 (5.5%) 58 (12.5%) (p< 0.001)
77 26/F¼ 3 (5); M¼ 4 (4) 76 28/F¼ 3 (5); M¼ 4 (6)
67 30 61 32
1 (4)/10.4 3.5 1 (4)/10.2 3.2
7.8 3.3/394 (84%) 8 3.2/384 (87%)
HA¼New York Heart Association; PP¼ polypathological patient; SD¼ standard
Table 3
Multivariate analysis of risk factors associated with 12-month functional decline in performing daily living activities (20 points fall in Barthel’s index with respect to basal
score), in the derivation cohort of polypathological patients from Spain.
Characteristic Odds ratio (conﬁdence interval)/p PROFUNCTION Index SIMPLIFIED PROFUNCTION
Demographics 85 yr 1.7 (1.032e2.81)/0.037 4 1
Clinical features
Chronic neurological condition (CAT E)a 1.6 (1.001e2.56)/0.049 4 1
Chronic osteoarticular disease (CAT H) 2.1 (1.13e3.9)/0.019 5 1
IIIeIV class in NYHA and/or MRC 1.75 (1.18e2.7)/0.014 4 1
Four or more polypathology categories 2.05 (1.1e3.8)/0.024 5 1
Functional-socio-familial features
Basal Barthel’s Index <60 2.27 (1.24e4.14)/0.008 5 1
Risk or established social problemb 1.52 (1.001e2.34)/0.048 4 1
TOTAL SCORE ITEMS¼7 0e31 points 0e7 points
a Cerebrovascular disease and/or any neurological diseases with signiﬁcant functional/cognitive impairment.
b by means of Gijón socio-familial risk score. MRC¼Medical Research Council; NYHA¼New York Heart Association.
M. Bernabeu-Wittel et al.72(p¼ 0.34/p¼ 0.13) in the HosmereLemeshow goodness-of-ﬁt test,
respectively.
All patients were assigned their respective PROFUNCTION index
(range: 0e31) and SIMPLIFIED PROFUNCTION scores (range: 0e7),
and divided into four different score groups. One-year functional
decline rates with respect to both indexes are detailed in Table 4.
Discrimination power of the PROFUNCTION index and SIMPLIFIED
PROFUCTION obtained in the derivation cohort was acceptable
[ROC curve area under the curve (AUC)¼ 0.574 (range: 0.52e0.629)
and 0.59 (range: 0.526e0.635), respectively].
3.2. Validation of PROFUNCTION index
Global functional decline rate in the validation cohort was 42%.
The obtained calibration in the derivation cohort was good
(p¼ 0.11/p¼ 0.09) in the HosmereLemeshow goodness-of-ﬁt test,
respectively. One-year functional decline rates with respect to both
indexes in the validation cohort are detailed in Table 4. Discrimi-
nation power of the PROFUNCTION index and SIMPLIFIED PRO-
FUCTION obtained in the derivation cohort was acceptable [ROC
curve AUC¼ 0.52 (range: 0.48e0.64), and 0.56 (range: 0.51e0.641),
respectively] as showed in Fig 2.
3.3. Comparison of PROFUNCTION index and SIMPLIFIED
PROFUNCTION with TRST and VIP indexes
Comparative discrimination power (AUC in the ROC curves) of
all evaluated and developed indexes are detailed in Fig. 2.
4. Discussion
In this study, we detected high rates of functional decline in
a multicenter sample of PPs during 1 year of follow-up. These rates
were higher than those detected in other studies handling geriatric
clinic patients of similar ages9,12,13,15,30. As a matter of fact, only 29%
of the PPs included remained alive and maintained their basalTable 4
Calibration of PROFUNCTION index and SIMPLIFIED PROFUNCTION in the derivation and v
a multicenter sample of polypathological patients from Spain.
Risk groups PROFUNCTION Index
Cohort Derivation Validation
First 0 points¼ 21% 0 points¼ 17%
Second 1e2 points¼ 23.2% 1e2 points¼ 2
Third 3e4 points¼ 34.5% 3e4 points¼ 3
Fourth  5 points¼ 39%  5 points¼ 42functional status for ADL; a similar rate to that obtained in the
Sanfeliu study, which included patients aged 90 years14. The
reason behind thismore severe functional disability of PPs probably
lies in their disease burden. Disease burden and clinical complexity
are some of the most characteristic issues of PPs, as reﬂected in
previous studies1,3. The functional data of this multicenter cohort
reveals that the new concept of polypathology is capable of
detecting vulnerable patients not only in terms of risk of death, but
also in terms of risk of dependence. The ADL whichmost frequently
declined were those related to self care (toilet use, grooming,
dressing and bathing), and probably are the result of motor,
balance, and cognitive decline. Additional explanations of this
pattern of functional decline probably lie in the high prevalence of
basal disability with respect to mobility, transfers, and climbing
stairs, which allowed only narrow rates to worsen in these
dimensions.
We detected poor discrimination power of recent tools speciﬁ-
cally designed for functional prognostication. In fact, both TRST and
VIP ﬁtted well, but their AUC in discriminating 1-year functional
deterioration was <0.5 in all three endpoint considerations (falls of
10, 20 and 30 points in BI). We believe that this scarce
discrimination relies on three factors. The ﬁrst could be the original
endpoints in their development (TRST was developed with the aim
of screening older patients’ risk of hospitalization, functional
decline, nursing home admission or readmission to an emergency
department; and VIP assesses older patients’ degree of indepen-
dence, with the aim of detecting patients with potential discharge
problems), which were quite different from ours (1-year functional
decline in ADL)15e17. The second reason probably relies on the main
features of PPs, which differ clearly from those of general geriatric
populations; in fact, one of the main and homogeneous charac-
teristics is their clinical complexity derived from the concurrence of
complex chronic diseases. This differential proﬁle points towards
the importance of including disease stratiﬁcation and burden, as
well as symptom load, as key and additional predictors of func-
tional decline. These important variables are not incorporated inalidation cohorts by functional-decline risk groups according to subgroups scores, in
SIMPLIFIED PROFUNCTION
Derivation Validation
0 points¼ 21% 0 points¼ 24%
5.4% 1e2 points¼ 30.2% 1e2 points¼ 33%
8.5% 3 points¼ 34.2% 3 points¼ 39%
% 4e7 points¼ 38% 4e7 points¼ 46%
Fig. 2. Comparative discrimination power of PROFUNCTION index, SIMPLIFIED PRO-
FUNCTION, TRST, and VIP indexes in predicting 12-month functional decline (loss of
20 points in Barthel’s index), in a multi-institutional sample of polypathological
patients from Spain, by means of ROC curves and determination of area under the
curve. ROC¼ receiver operating characteristic; TRST¼ Triage Risk Screening Tool;
VIP¼ Variable Indicative of Placement risk.
Functional Prognostication in Polypathology 73TRST or VIP indexes. Finally, the qualitative character of both scores
dividing patients into only two risk groups (low and high risk for
functional decline) predispose these indexes to adjustment losses
with respect to the groups of patients with intermediate risk, who
are classiﬁed with low or high functional decline risk.
Both indexes developed in our study, PROFUNCTION and
SIMPLIFIED PROFUNCTION proved a good calibration and accept-
able discrimination power in the derivation as well as in the vali-
dation cohorts. Because of the slight prognostic-weight differences
among the initial score items, we performed a simpliﬁed version by
making all items uniform in weight. After this simpliﬁcation, we
obtained very similar ﬁtness and discrimination values, therefore,
we suggest using the easier-to-perform simpliﬁed version. Our
SIMPLIFIED PROFUNCTION successfully stratiﬁed the patients into
four groups of functional decline risk, ranging from 21e24% in the
lowest stratum to 38e46% in the highest.
In reviewing the seven score items, there are two important
considerations upon which to remark. First, all of them have been
demonstrated as predictors of functional decline in previous
studies2,31e33; age is one of the main factors of functional status;
among diseases, the number of illnesses as well as speciﬁcally
neurological and osteoarticular disorders are narrowly correlated
with functional disability34,35; with respect to symptoms, the level
of dyspnea is probably one of the most disabling; ﬁnally both basal
functional status and socio-familial support are key predictors of
functional outcomes in all clinical and health-care scenarios32,33.
Second, their multidimensional nature confers strength to the
index, because of its ability to detect alterations or determinants of
future functionality in determined areas (demographic, clinical,
functional, or socio-familial), that are currently undetectable in
others. Many of the available tools are centered exclusively or
partially on only one area (e.g., clinical or functional), therefore,
they could be prone to lose accuracy, because they lack this
multidimensional integral approach.
In conclusion, functional decline is very prevalent in hospital-
based populations of PPs. We developed and validated a new func-
tional prognostic index speciﬁcally focused on PPs using seven
simplemeasures of different clinical areas that can be easily achieved
with a routine patient integral evaluation. The index had an accept-
able calibration and discrimination power and was successfully
validated in a geographically different cohort. It effectively stratiﬁedPPs into groups at varying risks of functional decline, and its ﬁtness
was better than other available functional prognostic tools.
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